Monographie - Phentolamine mesylate - Stabilis 4.0

Zadnji put ažurirano :
19/11/2024

vazodilatator

Phentolamine mesylate

injekcija

Stabilizacija rješenja

Stabilnost mješavine

Stabilizacijski faktor

Kompatibilnosti

način davanja lijeka

Bibliografija

pdf

Kemijska struktura

Nekomercijalni

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Ora Verse	Kanada, S A D
Phentolamine mesylate	Francuska
Regitine	Nizozemska

Bibliografija

injekcija

Bibliografija : Phentolamine mesylate

	Vrsta	Publikacija
456	Časopis	Tu YH, Allen LV, Wang DP. Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures. Am J Hosp Pharm 1987 ; 44: 2524-2527.
1036	Časopis	Hasegawa GR, Eder JF. Visual compatibility of amiodarone hydrochloride injection with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 1379-1380.
1041	Časopis	Hasegawa GR, Eder JF. Visual compatibility of dobutamine hydrochloride with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 949-951.
1057	Časopis	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1899	Časopis	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2150	Časopis	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
3172	Časopis	Xu F, Xu G, LSu L, Feng E. Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion. J Clin Pharm Ther 2011 ; 36, 1: 99-102.
4389	Časopis	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213

Mentions Légales